EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:176399 |
| ChEBI Name | inclisiran |
| Stars | |
| Definition | Inclisiran is a long-acting, synthetic small interfering RNA (siRNA) directed against PCSK9. It is indicated for the treatment of primary hypercholesterolemia (familial and non-familial) or mixed dyslipidemia in adults. |
| Last Modified | 14 June 2021 |
| Submitter | Bijay |
| Wikipedia |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| inclisiran (CHEBI:176399) is a organic molecular entity (CHEBI:50860) |
| INNs | Source |
|---|---|
| inclisiran | WHO MedNet |
| inclisiran | WHO MedNet |
| inclisirán | WHO MedNet |
| inclisiranum | WHO MedNet |
| Synonyms | Source |
|---|---|
| ALN-60212 | ChemIDplus |
| ALN-PCSsc | ChemIDplus |
| Brand Name | Source |
|---|---|
| Leqvio | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| D11931 | KEGG DRUG |
| DB14901 | DrugBank |
| Inclisiran | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:1639324-58-5 | ChemIDplus |
| Citations |
|---|